Serk In Park
Faculty Member
Last active: 4/26/2016

  1. Parathyroid hormone-related protein inhibits DKK1 expression through c-Jun-mediated inhibition of β-catenin activation of the DKK1 promoter in prostate cancer. Zhang H, Yu C, Dai J, Keller JM, Hua A, Sottnik JL, Shelley G, Hall CL, Park SI, Yao Z, Zhang J, McCauley LK, Keller ET (2014) Oncogene 33(19): 2464-77
    › Primary publication · 23752183 (PubMed) · PMC4004708 (PubMed Central)
  2. Osteal macrophages support physiologic skeletal remodeling and anabolic actions of parathyroid hormone in bone. Cho SW, Soki FN, Koh AJ, Eber MR, Entezami P, Park SI, van Rooijen N, McCauley LK (2014) Proc Natl Acad Sci U S A 111(4): 1545-50
    › Primary publication · 24406853 (PubMed) · PMC3910564 (PubMed Central)
  3. Dissecting the role of bone marrow stromal cells on bone metastases. Buenrostro D, Park SI, Sterling JA (2014) Biomed Res Int : 875305
    › Primary publication · 25054153 (PubMed) · PMC4099112 (PubMed Central)
  4. Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis. Ding X, Park SI, McCauley LK, Wang CY (2013) J Biol Chem 288(15): 10241-53
    › Primary publication · 23447531 (PubMed) · PMC3624408 (PubMed Central)
  5. Parathyroid hormone-related protein drives a CD11b+Gr1+ cell-mediated positive feedback loop to support prostate cancer growth. Park SI, Lee C, Sadler WD, Koh AJ, Jones J, Seo JW, Soki FN, Cho SW, Daignault SD, McCauley LK (2013) Cancer Res 73(22): 6574-83
    › Primary publication · 24072746 (PubMed) · PMC3838921 (PubMed Central)
  6. Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone. Jin R, Sterling JA, Edwards JR, DeGraff DJ, Lee C, Park SI, Matusik RJ (2013) PLoS One 8(4): e60983
    › Primary publication · 23577181 (PubMed) · PMC3618119 (PubMed Central)
  7. The multifaceted actions of PTHrP in skeletal metastasis. Soki FN, Park SI, McCauley LK (2012) Future Oncol 8(7): 803-17
    › Primary publication · 22830401 (PubMed) · PMC3566558 (PubMed Central)
  8. Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment. Jung Y, Shiozawa Y, Wang J, McGregor N, Dai J, Park SI, Berry JE, Havens AM, Joseph J, Kim JK, Patel L, Carmeliet P, Daignault S, Keller ET, McCauley LK, Pienta KJ, Taichman RS (2012) Neoplasia 14(5): 429-39
    › Primary publication · 22745589 (PubMed) · PMC3384430 (PubMed Central)
  9. Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells. Park SI, McCauley LK (2012) Endocr Relat Cancer 19(3): 243-54
    › Primary publication · 22291434 (PubMed) · PMC3593272 (PubMed Central)
  10. Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis. Park SI, Liao J, Berry JE, Li X, Koh AJ, Michalski ME, Eber MR, Soki FN, Sadler D, Sud S, Tisdelle S, Daignault SD, Nemeth JA, Snyder LA, Wronski TJ, Pienta KJ, McCauley LK (2012) Cancer Res 72(10): 2522-32
    › Primary publication · 22589273 (PubMed) · PMC3457788 (PubMed Central)